Equity · Healthcare
EMBC
NASDAQEmbecta (EMBC)
The line runs 5 USD on 31 August through 5.95 USD on 6 October, on a scale from 4.5 to 6.0. Days the market did not trade hold the previous close, flat.
- Market cap
- 336.8M USD
- P/E (TTM)
- 4.0
- Revenue, year to Sep 2025
- 1.1B USD
- EPS, diluted, year to Sep 2025
- 1.62 USD
- 52-week range
- 3 USD – 14.72 USD
- Avg volume
- 109.0K
as of Oct 6, 2026
Have Embecta (EMBC) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Embecta insiders reported 1 open-market sale and 4 purchases (SEC Form 4).
Form 4, 90 days to 10 Nov 2026, newest reported trade 4 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 04 Sep 2026 | Morris Milton MayoDirector | Sell | 6,293 | 37K USD |
| 12 Aug 2026 | Kurdikar DevdattPresident and CEO | Buy | 30,000 | 141K USD |
| 12 Aug 2026 | Elguicze JacobSVP and CFO | Buy | 20,000 | 93K USD |
| 12 Aug 2026 | Mann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLO | Buy | 20,000 | 100K USD |
| 12 Aug 2026 | HOMBACH ROBERT J.Director | Buy | 45,000 | 224K USD |
| Bought | 4 open-market purchases | 115,000 | $558K | |
| Sold | 1 open-market sale | 6,293 | $37K |
Which funds hold Embecta (EMBC)?
7 of the 45 institutional funds we track reported a Embecta position for the quarter ended 30 Jun 2026 — a combined 11.6M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Added | 976,587 | 3.2M USD | +194.5% |
| Millennium Management | Trimmed | 945,968 | 3.1M USD | −40.7% |
| D. E. Shaw & Co. | Held (±25%) | 650,070 | 2.1M USD | +22.1% |
| Citadel Advisors | Held (±25%) | 446,091 | 1.5M USD | +13.9% |
| Marshall Wace | Held (±25%) | 357,188 | 1.2M USD | −15.2% |
| Balyasny Asset Management | New position | 161,997 | 528K USD | |
| Point72 Asset Management | New position | 20,236 | 66K USD | |
| GAMCO Investors | Exited | |||
| Man Group | Exited | |||
| Renaissance Technologies | Exited |
What has been filed or recorded for Embecta (EMBC)?
The filings we hold for Embecta, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 08 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 17 shares | 100 USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 3,259 shares | 18K USD notional · 0.006% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 681 shares | 4K USD notional · 0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.36 USD | |
| 30 Jun 2026 | Financials | Total assets | 1.3B USD | at period end |
| 30 Jun 2026 | Financials | Total equity | −612.7M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.07 USD | |
| 31 Dec 2025 | Quarterly earnings | Q1 2026 reported | EPS 0.74 USD | |
| 30 Sep 2025 | Annual report | FY 2025 reported | EPS 1.62 USD | |
| 30 Sep 2025 | Financials | Revenue | 1.1B USD | fiscal year |
| 30 Sep 2025 | Financials | Net income | 95.4M USD | fiscal year |
| 30 Sep 2025 | Financials | Diluted EPS | 1.62 USD | fiscal year |
| 30 Jun 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.78 USD | |
| 31 Mar 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.40 USD | |
| 31 Dec 2024 | Quarterly earnings | Q1 2025 reported | EPS 0.00 USD | |
| 30 Sep 2024 | Annual report | FY 2024 reported | EPS 1.34 USD |
What do people ask about Embecta (EMBC)?
What did Embecta shares close at?5.95
Embecta closed at 5.95 USD on 6 Oct 2026, up 0.76% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Embecta’s market cap?336.8M
Embecta is worth 336.8M USD by market value as of 6 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Embecta’s P/E ratio?4.0
Embecta has a price-to-earnings ratio of 4.0, as of 6 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Embecta’s revenue?1.1B
Embecta reported revenue of 1.1B USD for the year ended 30 Sep 2025, as filed with the SEC. See Filings
Have Embecta insiders bought or sold shares recently?1 sale
In the 90 days to 10 Nov 2026, Embecta insiders reported 1 open-market sale and 4 purchases (SEC Form 4). See Insiders
Which funds own Embecta?7 of 45
7 of the 45 funds we track reported a Embecta position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Millennium Management and D. E. Shaw & Co. See Funds
When did Embecta last report earnings?0.36
Embecta last reported earnings on 30 Jun 2026 for Q3 2026, with EPS of 0.36 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings